clinivation

  • Sign In
  • Contact
  • About
    • What We Do
    • Newsroom
    • Our Partners
    • Events
    • Careers
    • Contact
  • Solutions
    • Business Development
    • Clinical Operations
    • Commercial Operations
    • Health Policy & Reimbursement
    • Medical Affairs
    • Portfolio Management
    • Regulatory Affairs
    • Research & Development
  • Products
    • CareSite
    • ClinicalSuite
    • Cloud
    • Conformity
    • ForeSight
    • Global
    • Prospectus
    • RealWorld
    • RegistrySuite
    • ValueLogic
    • WorldView
  • Services & Support
    • Customer Support
    • Solution Services
    • CRO Services
    • Professional Services
    • Innovation Workshops
  • Resources
    • Data Sheets
  • Customers
    • Customer Success
Home / News / Given Imaging, Ltd. Selects Clinivation Global 2.0.
clinivation
CONTACT US

Given Imaging, Ltd. Selects Clinivation Global 2.0.

Emerging leader in gastrointestinal diagnostic imaging products selects Global 2.0 to manage its medical devices approvals and submissions worldwide.

Framingham, MA, January 10, 2006 – clinivation, Inc. announced today that Given Imaging, Ltd. (NASDAQ NM: GIVN) has selected clinivation Global™ 2.0 software.

“Given Imaging technology has been recognized as the gold standard in detecting disease of the small intestine,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer. “We are delighted that Given Imaging’s management has selected clinivation Global 2.0 to help them build and track their medical device approvals and submissions worldwide,” he continued.

Clinivation Global 2.0 software enables medical device companies to sell more products to more countries faster and easier than ever before. Global 2.0 is the first complete solution targeted at automating the business processes for medical device approvals worldwide.

About Given Imaging, Ltd.

Given Imaging is redefining gastrointestinal diagnosis by developing, producing and marketing innovative, patient-friendly products for detecting gastrointestinal disorders. The company is developing a complete line of PillCam™ video capsules for detecting disorders of the gastrointestinal tract. The company’s technology platform is the Given® Diagnostic System, featuring the PillCam video capsule, a disposable, miniature video camera contained in a capsule, which is ingested by the patient.

The PillCam™ SB capsule is the only naturally ingested method for direct visualization of the entire small intestine. It is currently marketed in the United States and in more than 50 other countries and has benefited more than 260,000 patients worldwide. The PillCam™ ESO video capsule, which provides visual examination of the esophagus, has been cleared for marketing by the FDA. Additional capsules for visualization of the stomach and colon are under development. Given Imaging’s headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel; it has direct sales and marketing operations in the United States, Germany and France, and local offices in Japan, Spain and Australia.

For more information, visit www.givenimaging.com

Share

About clinivation

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

Media Contact

Corporate Communications
irpr@clinivation.com

clinivation, Inc.
Suite 1800
245 First Street
Cambridge, MA 02142
U.S.A.
Phone +1 617‐444‐8500

About

  • What We Do
  • Newsroom
  • Our Partners
  • Events
  • Careers
  • Contact

Solutions

  • Business Development
  • Clinical Operations
  • Commercial Operations
  • Health Policy & Reimbursement
  • Medical Affairs
  • Portfolio Management
  • Regulatory Affairs
  • Research & Development

Products

  • CareSite
  • ClinicalSuite
  • Cloud
  • Conformity
  • ForeSight
  • Global
  • Prospectus
  • RealWorld
  • RegistrySuite
  • ValueLogic
  • WorldView

Services & Support

  • Customer Support
  • Solution Services
  • CRO Services
  • Professional Services
  • Innovation Workshops

Resources

  • Data Sheets

Customers

  • Customer Success
American Flag US: +1 (617) 444‐8500
Contact Us
  • Privacy
  • Terms Of Use
  • Trademarks
  • Site Map

© 2025 · clinivation, INC.

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly
connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions
that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

​